Symproic (Purdue Pharma LP)


Welcome to the PulseAid listing for the Symproic drug offered from Purdue Pharma LP. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Purdue Pharma LP
NON-PROPRIETARY NAME: naldemedine
SUBSTANCE NAME: NALDEMEDINE TOSYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Opioid Antagonist [EPC],Opioid Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-03-23
END MARKETING DATE: 0000-00-00


Symproic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSymproic from Purdue Pharma LP
LABELER NAME: Purdue Pharma LP
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/1)
START MARKETING DATE: 2017-03-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59011-523_0b82784a-f477-4107-9e4a-a1490a603262
PRODUCT NDC: 59011-523
APPLICATION NUMBER: NDA208854

Other NALDEMEDINE TOSYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Purdue Pharma LPSymproic